MicroCarb
This article was originally published in The Tan Sheet
Executive Summary
Signs preliminary joint venture agreement with Hughes Labs covering OTC and prescription marketing rights to an unnamed drug for the treatment of cold sores and genital herpes. Gaithersburg, Md.-based MicroCarb plans to initially market the drug as an OTC treatment for cold sores while the company begins the clinical development process to support prescription marketing of the drug as a genital herpes treatment. The joint venture agreement also would cover three patents held by Hughes covering the antiviral product. MicroCarb has a 90-day period to obtain financing of a minimum of $5 mil. for the deal
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning